Astrana Health, Inc. financials

  1. Home
  2. Financials
  3. ASTH
ASTH CIK 0001083446

Source: EDGAR filings · Built 2026-06-02T02:22:58Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 104.49M 43.50M 39.02M 58.62M 50.90M 44.89M
EBITDA 124.27M 117.28M 102.36M 121.81M 115.70M 98.85M
Working Capital 248.04M 272.89M 242.83M 279.51M 289.74M 223.59M
Net Debt 662.13M 186.82M 30.77M -55.34M -27.85M 71.69M
Gross Margin — — — — 22.97% 21.53%
Operating Margin 2.47% 4.39% 6.10% 9.11% 12.69% 11.71%
Net Margin 0.71% 2.12% 4.38% 3.95% 8.91% 5.48%
Return on Equity (ROE) 2.89% 6.05% 9.89% 8.33% 15.38% 11.39%
Return on Assets (ROA) 1.01% 3.18% 6.51% 4.68% 7.95% 4.61%
Current Ratio 1.40× 1.75× 2.11× 2.88× 3.53× 2.94×
Debt-to-Equity 1.40× 0.67× 0.53× 0.43× 0.46× 0.80×
Effective Tax Rate 39.21% 38.22% 35.61% 47.19% 40.76% 31.58%
Cash Conversion Ratio 5.10× 1.21× 1.12× 1.82× 1.02× 1.22×
Accruals Ratio -0.04× -0.01× -0.01× -0.04× -0.00× -0.01×
SBC % of Revenue 1.21% 1.70% 1.59% 1.41% 0.87% 0.49%
CapEx Coverage 11.34× 6.00× 2.34× 3.49× 3.62× 36.38×
Free Cash Flow Per Share $2.12 $0.91 $0.83 $1.29 $1.12 $1.20

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 53.93× 35.03× 29.69× 29.89× 48.34× 18.09×
P/FCF 11.72× 34.77× 46.07× 23.02× 65.54× 15.24×
FCF Yield 8.53% 2.88% 2.17% 4.34% 1.53% 6.56%
EV / EBITDA 15.09× 14.48× 17.83× 10.86× 28.11× 8.53×
P/S 0.38× 0.74× 1.29× 1.20× 4.24× 1.12×
P/B 1.56× 2.12× 2.92× 2.54× 7.32× 2.33×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 3.18B 2.03B 1.39B 1.14B 773.91M 687.18M
Cost of Goods and Services Sold — — — — 596.14M 539.21M
Operating Income (Loss) 78.53M 89.35M 84.61M 104.27M 98.18M 80.50M
Income Tax Expense (Benefit) 15.53M 30.89M 31.99M 40.88M 31.69M 56.34M
Net Income (Loss) Attributable to Parent 22.49M 43.15M 60.72M 45.17M 68.92M 37.69M
Earnings Per Share, Basic $0.46 $0.91 $1.30 $1.00 $1.57 $1.03
Weighted Average Number of Shares Outstanding, Basic 49.08M 47.60M 46.55M 44.97M 43.83M 36.53M
Earnings Per Share, Diluted $0.46 $0.90 $1.29 $0.99 $1.52 $1.01
Weighted Average Number of Shares Outstanding, Diluted 49.37M 47.97M 46.94M 45.60M 45.40M 37.45M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 429.47M 288.45M 293.81M 288.03M 233.10M 193.47M
Assets, Current 863.31M 638.50M 461.51M 428.13M 404.46M 338.58M
Assets 2.22B 1.35B 933.36M 966.21M 867.36M 817.49M
Liabilities, Current 615.27M 365.61M 218.67M 148.61M 114.72M 114.99M
Long-term Debt, Excluding Current Maturities 990.90M 425.30M 258.94M 203.39M 182.92M 230.21M
Liabilities 1.66B 840.73M 522.59M 407.67M 356.72M 372.34M
Stockholders' Equity Attributable to Parent 779.29M 712.72M 614.22M 542.56M 448.17M 330.82M
Common Stock, Shares, Outstanding 48.89M 47.93M — 46.58M 44.63M 42.25M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 114.60M 52.20M 68.23M 82.13M 70.33M 46.16M
Payments to Acquire Property, Plant, and Equipment 10.11M 8.03M 28.53M 22.94M 19.22M 1.16M
Net Cash Provided by (Used in) Investing Activities -539.00M -192.40M -65.52M -7.11M 16.54M 95.49M
Payments for Repurchase of Common Stock 25.60M 900.00K 10.19M 9.25M 5.74M 537.00K
Net Cash Provided by (Used in) Financing Activities 569.35M 135.15M 3.42M -20.09M -47.75M -51.70M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ASTH CIK 0001083446), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

BRZE

Braze, Inc.

JBHT

J.B. HUNT TRANSPORT SERVICES, INC.

SI

Shoulder Innovations, Inc.